Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Available from: Vu AC Han
SGLT2is remained cost-effective at a threshold of AU$28,000 per QALY gained under all scenarios in the total and secondary prevention populations, except when the price of SGLT2is was set at AU$7000 (US price), when the timeframe was reduced to 20202030, and when the efficacy was reduced by 5% per year
In this episode, Dr
After 52 weeks of treatment, the proportion of participants in the oral semaglutide group achieving an A1C of less than 7.0% was 58.3% (treatment-policy estimand) and 62.8% (trial-product estimand), compared with 25.2% (treatment-policy estimand) and 28.3% (trial-product estimand) for the group receiving 100 mg of sitagliptin daily
US$ 27.31
US$ 29.39
US$ 29.44
US$ 25.74
US$ 23.31
US$ 26.41
US$ 29.74
US$ 26.29
US$ 21.37
